New patent for Boehringer Ingelheim drug JENTADUETO

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are eleven patents…
The post New patent for Boehringer Ingelheim drug JENTADUETO a…


Biotechblog